 Fibrocystic disease breast premenopausal women histohormonal correlation response hormone hormone analog treatment Sixty-six patients fibrocystic mastopathy trial clinical radioultrasonographic histologic criteria No characteristic hormonal profile patients Estrogen receptors progesterone receptors patients Hormone receptor levels atypical proliferative mastopathy Mastopathy uterine fibroma fibromatous uterus cases patients intramuscular injections delivery system microcapsules hormone hormone agonist -LHRH Ipsen-Biotech Paris months case partial response months antiestrogen tamoxifen mg/day estrogen receptor-predominant lesions progestin cyproterone acetate mg/day progesterone receptor-predominant lesions hormone hormone agonist complete response half patients -LHRH tamoxifen cyproterone acetate significant partial response patients half inhibitory drugs responses cyst reformation complete response fibrous block Clinical responses treatment -LHRH independent hormone receptor status synergistic effects concomitant use corresponding inhibitory drugs chronic mastopathy uterine fibroma hormone hormone analogs premenopausal women